352 related articles for article (PubMed ID: 22580117)
1. Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
Caravatta L; Padula GD; Macchia G; Ferrandina G; Bonomo P; Deodato F; Massaccesi M; Mignogna S; Tambaro R; Rossi M; Flocco M; Scapati A; Scambia G; Pacelli F; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e627-31. PubMed ID: 22580117
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Padula GD; Mignogna S; Tambaro R; Carrozza F; Flocco M; Cantore G; Scapati A; Buwenge M; Sticca G; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e463-8. PubMed ID: 22909415
[TBL] [Abstract][Full Text] [Related]
3. Palliative Short-course Radiotherapy in Advanced Pelvic Cancer: A Phase II Study (SHARON Project).
Farina E; Macchia G; Siepe G; Zamagni A; Buwenge M; Scirocco E; Cellini F; Deressa BT; Tigeneh W; Uddin KAFM; Sumon MA; Caravatta L; Genovesi D; Mauro FA; Cammelli S; Cilla S; Morganti AG; Deodato F
Anticancer Res; 2019 Aug; 39(8):4237-4242. PubMed ID: 31366511
[TBL] [Abstract][Full Text] [Related]
4. Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Tambaro R; Mignogna S; Padula GD; Musacchio M; Flocco M; Cantore G; Scapati A; Bogale S; Balducci M; Valentini V; Cellini N; Morganti AG
Am J Clin Oncol; 2015 Aug; 38(4):395-400. PubMed ID: 26214084
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
7. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
[TBL] [Abstract][Full Text] [Related]
8. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Short-course, intensity-modulated radiotherapy for localized prostate cancer.
Kupelian PA; Willoughby TR
Cancer J; 2001; 7(5):421-6. PubMed ID: 11693901
[TBL] [Abstract][Full Text] [Related]
11. Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.
Gatti M; Ponzone R; Bresciani S; Panaia R; Kubatzki F; Maggiorotto F; Di Virgilio MR; Salatino A; Baiotto B; Montemurro F; Stasi M; Gabriele P
Breast; 2013 Dec; 22(6):1136-41. PubMed ID: 23958374
[TBL] [Abstract][Full Text] [Related]
12. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation of amifostine for radioprotection during pelvic accelerated radiotherapy.
Koukourakis MI; Kyrgias G; Panteliadou M; Papadopoulou A; Tsiarkatsi M; Papachristou E; Bebeli M
Am J Clin Oncol; 2013 Aug; 36(4):338-43. PubMed ID: 22643562
[TBL] [Abstract][Full Text] [Related]
14. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
[TBL] [Abstract][Full Text] [Related]
15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
16. Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study.
Cameron MG; Kersten C; Vistad I; van Helvoirt R; Weyde K; Undseth C; Mjaaland I; Skovlund E; Fosså SD; Guren MG
Acta Oncol; 2016 Dec; 55(12):1400-1407. PubMed ID: 27332723
[TBL] [Abstract][Full Text] [Related]
17. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
[TBL] [Abstract][Full Text] [Related]
18. Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: initial report of American College of Radiology Phase II study 03-12.
Coen JJ; Bae K; Zietman AL; Patel B; Shipley WU; Slater JD; Rossi CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1005-9. PubMed ID: 20932675
[TBL] [Abstract][Full Text] [Related]
19. Short-course regimen of palliative radiotherapy in complicated bone metastases: a phase i-ii study (SHARON Project).
Capuccini J; Macchia G; Farina E; Buwenge M; Genovesi D; Caravatta L; Nguyen NP; Cammelli S; Cilla S; Wondemagegnhu T; Uddin AFMK; Aziz Sumon M; Cellini F; Valentini V; Deodato F; Morganti AG
Clin Exp Metastasis; 2018 Oct; 35(7):605-611. PubMed ID: 30121938
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
